Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of early ventilator-associated pneumonia after cardiac arrest with amoxicillin-clavulanate
2014-000202-35Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amoxicillin + clavulanate in ventilator-associated pneumonia (VAP), pneumonia and alveolitis (2 arms), sponsored by CHU de Limoges. Primary endpoint: Onset of early ventilator-associated pneumonia. Started Jun 2015; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
ventilator-associated pneumonia (VAP)pneumoniaalveolitis
Beyond the preview
Go deeper on 2014-000202-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000202-35.